Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.

Journal of tropical pediatrics - 1 Apr 2017

Boerma Ragna S, Kityo Cissy, Boender T Sonia, Kaudha Elizabeth, Kayiwa Joshua, Musiime Victor, Mukuye Andrew, Kiconco Mary, Nankya Immaculate, Nakatudde Lilian, Mugyenyi Peter N, Boele van Hensbroek Michael, Rinke de Wit Tobias F, Sigaloff Kim C E, Calis Job C J

Abstract excerpt

Background: Data on pediatric second-line antiretroviral treatment (ART) outcomes are scarce, but essential to evaluate second-line and design third-line regimens. Methods: Children ≤12 years switching to second-line ART containing a protease inhibitor (PI) in Uganda were followed for 24 months. Viral load (VL) was determined at switch to second-line and every 6 months thereafter; genotypic resistance testing was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Black People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Protease Inhibitors

Share to Treatment Failure

Share to Uganda

Share to Viral Load

Source

Identifiers

PMID: 27634175
DOI: 10.1093/tropej/fmw062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Second-line HIV Treatment in Ugandan Children: Favorable Outcomes and No Protease Inhibitor Resistance.PMID 27634175Read ↗

Pretreatment HIV drug resistance results in virological failure and accumulation of additional resistance mutations in Ugandan children.Semantic proximity Read ↗

Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy.Semantic proximity Read ↗

Predictors of Failure on Second-line Antiretroviral Therapy with Protease Inhibitor Mutations in UgandaSemantic proximity Read ↗

Low Levels of Clinically Significant Drug Resistance Mutations to Dolutegravir Among Children Living with HIV Failing on First-Line Antiretroviral Therapy in Uganda.Semantic proximity Read ↗

Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children.Semantic proximity Read ↗

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.Semantic proximity Read ↗

Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.Semantic proximity Read ↗

Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.Semantic proximity Read ↗

High levels of pre-treatment HIV drug resistance and treatment failure in Nigerian children.Semantic proximity Read ↗

Pediatric response to second-line antiretroviral therapy in South Africa.Semantic proximity Read ↗

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda.Semantic proximity Read ↗

Pretreatment HIV drug resistance predicts accumulation of new mutations in ART-naïve Ugandan children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.